期刊文献+

通秘合剂治疗老年性便秘临床研究 被引量:8

Clinical Research of Tongmi Mixture in the Treatment of Senile Constipation
下载PDF
导出
摘要 目的:观察通秘合剂治疗老年性便秘的临床疗效。方法:将158例老年性便秘患者随机分为治疗组和对照组。治疗组96例给予通秘合剂口服,对照组62例给予芪蓉润肠口服液口服。观察两组治疗前、治疗后和治疗后1个月患者排便周期、排便时费力程度、排便时间、不尽感、便质情况、便意感等主要临床症状积分情况,并统计临床疗效。结果:治疗后治疗组有效率为86.5%,对照组有效率为74.2%,两组比较,差异有统计学意义(P<0.05)。在改善患者排便频率,费力程度,排便不尽感,便质性状等临床症状方面明显优于对照组,差异有统计学意义(P<0.05);1个月后随访,治疗组有效率为73.1%,对照组有效率为48.1%,两组比较,差异有统计学意义(P<0.05)。结论:通秘合剂治疗老年性便秘临床疗效显著。 Objective:To investigate clinical effect of Tongmi mixture in the treatment of senile constipation. Methods:158 cases with se-nile constipation were randomly divided into control group and treatment group. The treatment group was given Tongmi mixture and the control group was treated with Qirong Runchang oral liquid. Clinical symptoms such as abdominal pain,diarrhea,mucous stool with pus and blood,tenesmus signs of two groups were analyzed. Clinical curative effects of two groups were analyzed by colonoscopy. Results:Af-ter treatment,the total effective rate of treatment group and control group were 86. 5% and 74. 2% . The difference was statistically (P ﹤ 0. 05). In improving defecation frequency,exertion degree,stool character such clinical symptoms,treatment group improved more significantly than that of the control group(P ﹤ 0. 05). Follow up after one month,the effective rate was 73. 1% in treatment group and 48. 1% in control group,the difference was statistically(P ﹤ 0. 05). Conclusion:Tongmi mixture in the treatment of senile constipation has significant clinical efficacy.
出处 《中医学报》 CAS 2015年第9期1351-1353,共3页 Acta Chinese Medicine
基金 国家自然科学基金项目(78201501) 河南省教育基础研究项目(15A360006)
关键词 老年性便秘 通秘合剂 气阴两虚证 senile constipation tongmi mixture Qi-Yin asthenia syndrome
  • 相关文献

参考文献11

二级参考文献40

  • 1王国声.便秘辨治体会[J].实用中医内科杂志,2005,19(1):27-27. 被引量:1
  • 2功能性胃肠病罗马Ⅲ诊断标准[J].胃肠病学,2006,11(12):761-765. 被引量:744
  • 3丁义江,丁曙晴.慢性功能性便秘的中医诊治策略[J].中国临床医生杂志,2007,35(3):18-19. 被引量:27
  • 4Voderholzer WA, Schatke W, M fihldoHer BE, et al. Clinical response to dietary fiber treatment of chronic constipation [ J]. Am J Gastroenterol, 1997,92 ( 1 ) : 95 - 98.
  • 5Inui A, Yoshikawa T, Nagai R, et al. Effects of mosapride citrate, a5 - HT4receptor agonist, on colonic motility in conscious guinea pigs [ J ]. Jpn J Pharmacol,2002,90(4) :313 -320.
  • 6Drossman DA. The functional gastrointestial disorders [ M ]. 2nd ed. USA : Allen Press ,2000 : 1 - 108.
  • 7Shimatani H, Kojima Y, Kadowaki M, et al. A5 - HT4agonist mosapride enhances rectorectal and rectoanal reflexes in guinea pigs[ J]. Am J Physiol Gastrointest Liver Physiol,2003,285 (2) : 389 - 395.
  • 8Fishman L,Lenders C,Fortunato C,et al.Increased prevalence of constipation and fecal soiling in a population of obese children[J].J Pediatr,2004,145(2):253
  • 9Voderholzer WA,Schatke W,Mühldorfer BE,et al.Clinical response to dietary fiber treatment of chronic constipation[J].Am J Gastroenterol,1997,92:95.
  • 10中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中华人民共和国卫生部制定发布,1993:143

共引文献428

同被引文献132

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部